These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Prenatal detection of congenital heart disease in a low risk population undergoing first and second trimester screening. Jørgensen DE; Vejlstrup N; Jørgensen C; Maroun LL; Steensberg J; Hessellund A; Jørgensen FS; Larsen T; Shalmi AC; Skibsted L; Zingenberg H; Ekelund C; Tabor A Prenat Diagn; 2015 Apr; 35(4):325-30. PubMed ID: 25352400 [TBL] [Abstract][Full Text] [Related]
25. Increased nuchal translucency and pregnancy outcome: a retrospective study of 1063 consecutive singleton pregnancies in a single referral institution. Ayräs O; Tikkanen M; Eronen M; Paavonen J; Stefanovic V Prenat Diagn; 2013 Sep; 33(9):856-62. PubMed ID: 23613307 [TBL] [Abstract][Full Text] [Related]
26. Fetal nuchal translucency in severe congenital heart defects: experiences in Northern Finland. Alanen J; Leskinen M; Sairanen M; Korpimaki T; Kouru H; Gissler M; Ryynanen M; Nevalainen J J Matern Fetal Neonatal Med; 2019 May; 32(9):1454-1460. PubMed ID: 29157037 [TBL] [Abstract][Full Text] [Related]
27. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age. Mula R; Goncé A; Bennásar M; Arigita M; Meler E; Nadal A; Sánchez A; Botet F; Borrell A Ultrasound Obstet Gynecol; 2012 Jan; 39(1):34-41. PubMed ID: 21837766 [TBL] [Abstract][Full Text] [Related]
28. Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac. Bekker MN; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM Obstet Gynecol; 2006 Oct; 108(4):846-53. PubMed ID: 17012445 [TBL] [Abstract][Full Text] [Related]
29. Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis. Sotiriadis A; Papatheodorou S; Eleftheriades M; Makrydimas G Ultrasound Obstet Gynecol; 2013 Oct; 42(4):383-9. PubMed ID: 23606595 [TBL] [Abstract][Full Text] [Related]
30. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183 [TBL] [Abstract][Full Text] [Related]
31. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome]. Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544 [TBL] [Abstract][Full Text] [Related]
32. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Atzei A; Gajewska K; Huggon IC; Allan L; Nicolaides KH Ultrasound Obstet Gynecol; 2005 Aug; 26(2):154-7. PubMed ID: 15977311 [TBL] [Abstract][Full Text] [Related]
33. Prenatal diagnosis and outcome for fetuses with congenital absence of the pulmonary valve. Galindo A; Gutiérrez-Larraya F; Martínez JM; Del Rio M; Grañeras A; Velasco JM; Puerto B; Gratacos E Ultrasound Obstet Gynecol; 2006 Jul; 28(1):32-9. PubMed ID: 16795129 [TBL] [Abstract][Full Text] [Related]
34. Pregnancy outcome of euploid fetuses with increased nuchal translucency: how bad is the news? Maymon R; Weinraub Z; Herman A J Perinat Med; 2005; 33(3):191-8. PubMed ID: 15914340 [TBL] [Abstract][Full Text] [Related]
35. Is there any relationship between adverse pregnancy outcome and first trimester nuchal translucency measurements in normal karyotype fetuses? Uysal F; Coşar E; Yücesoy K; Gencer M; Cevizci S; Güngör A; Hacıvelioğlu S; Uysal A J Matern Fetal Neonatal Med; 2015 Mar; 28(5):531-4. PubMed ID: 24824104 [TBL] [Abstract][Full Text] [Related]
36. First-trimester measurement of the ductus venosus pulsatility index and the prediction of congenital heart defects. Timmerman E; Clur SA; Pajkrt E; Bilardo CM Ultrasound Obstet Gynecol; 2010 Dec; 36(6):668-75. PubMed ID: 20617506 [TBL] [Abstract][Full Text] [Related]
37. [Increased fetal nuchal translucency thickness and normal karyotype: prenatal and postnatal follow-up]. Saldanha FA; Brizot Mde L; Moraes EA; Lopes LM; Zugaib M Rev Assoc Med Bras (1992); 2009; 55(5):575-80. PubMed ID: 19918659 [TBL] [Abstract][Full Text] [Related]
38. [Analysis for the pregnancy outcome of cystic hygroma fetuses and correlation with increased nuchal translucency in first trimester]. Wang Q; Wang X Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):665-670. PubMed ID: 30369121 [No Abstract] [Full Text] [Related]
39. The role of nuchal translucency in the screening for congenital heart defects. Bruns RF; Moron AF; Murta CG; Gonçalves LF; Zamith MM Arq Bras Cardiol; 2006 Sep; 87(3):307-14. PubMed ID: 17057931 [TBL] [Abstract][Full Text] [Related]
40. A significant linear association exists between nuchal translucency thickness and adverse perinatal outcome in euploid fetuses. Sheizaf B; Sheiner E; Fink M; Hershkovitz R; Mazor M; Wiznitzer A J Matern Fetal Neonatal Med; 2009 Jun; 22(6):479-84. PubMed ID: 19479642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]